Valupak Vitamins Limited Company accounts
Valupak Vitamins Limited Company accounts
COMPANY REGISTRATION NUMBER:
8992422
|
|
|
|
Financial Statements |
Year ended 30 April 2022
Contents |
Page |
Officers and professional advisers |
1 |
Director's report |
2 |
Chartered accountant's report to the director on the preparation of the unaudited statutory financial statements |
3 |
Statement of financial position |
4 |
Notes to the financial statements |
5 |
|
Officers and Professional Advisers |
Director |
|
Registered office |
|
|
|
|
|
West Yorkshire |
|
|
|
Accountants |
|
Chartered accountants |
|
Third Floor |
|
10 South Parade |
|
Leeds |
|
LS1 5QS |
|
|
Director's Report |
Year ended 30 April 2022
The director presents his report and the unaudited financial statements of the company for the year ended
30 April 2022
.
The company has been dormant as defined in section 1169 of the Companies Act 2006 throughout the year and preceding financial year. It is anticipated that the company will remain dormant for the foreseeable future.
Director
The director who served the company during the year was as follows:
|
|
Small company provisions
This report was approved by the board of directors on
24 November 2022
and signed on behalf of the board by:
|
|
Director |
|
Registered office: |
|
|
|
West Yorkshire |
|
|
Chartered Accountant's Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of
|
Year ended 30 April 2022
Third Floor
10 South Parade
Leeds
LS1 5QS
|
Statement of Financial Position |
2022 |
2021 |
|
Note |
£ |
£ |
Current assets
Debtors |
4 |
|
|
---- |
---- |
||
Net current assets |
|
|
|
---- |
---- |
||
Total assets less current liabilities |
|
|
|
---- |
---- |
||
Capital and reserves
Called up share capital |
|
|
---- |
---- |
|
Shareholders funds |
|
|
---- |
---- |
|
The company did not trade during the current year or prior year and has not made either a profit or loss.
Director's responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476
;
-
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
These financial statements were approved by the
board of directors
and authorised for issue on
24 November 2022
, and are signed on behalf of the board by:
|
|
Director |
|
Company registration number:
8992422
|
Notes to the Financial Statements |
Year ended 30 April 2022
1.
General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Clayton Wood Close, West Park Ring Road, Leeds, LS16 6QE, West Yorkshire.
2.
Statement of compliance
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in shareholders funds during the current year or prior year.
4.
Debtors
2022 |
2021 |
|
£ |
£ |
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
|
|
---- |
---- |
|
5.
Related party transactions
There are no disclosable related party transactions.
6.
Controlling party
In the opinion of the directors the ultimate controlling party is B R Pharmaceuticals Limited, a company registered in England and Wales.